BONAVITA, SIMONA
 Distribuzione geografica
Continente #
AS - Asia 79
NA - Nord America 79
EU - Europa 47
SA - Sud America 31
AF - Africa 3
Totale 239
Nazione #
US - Stati Uniti d'America 78
SG - Singapore 33
BR - Brasile 25
VN - Vietnam 17
CN - Cina 15
DE - Germania 15
IT - Italia 10
FI - Finlandia 8
IN - India 8
SE - Svezia 7
EC - Ecuador 3
GB - Regno Unito 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
ZA - Sudafrica 2
AR - Argentina 1
BD - Bangladesh 1
CA - Canada 1
CO - Colombia 1
ES - Italia 1
IQ - Iraq 1
KR - Corea 1
MA - Marocco 1
PY - Paraguay 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 239
Città #
Singapore 17
Munich 14
Turku 8
Dallas 6
Bengaluru 5
Chandler 5
Hefei 5
Ho Chi Minh City 5
Lawrence 5
Princeton 5
Santa Clara 5
Milan 4
Xian 4
Ashburn 3
Beijing 3
London 3
Wilmington 3
Augusta 2
Biên Hòa 2
Brasília 2
Chicago 2
Des Moines 2
Hong Kong 2
Olomouc 2
Quito 2
Angra dos Reis 1
Barretos 1
Basīrhat 1
Bình An 1
Cao Lanh 1
Cape Town 1
Carmópolis de Minas 1
Casablanca 1
Clearwater 1
Colorado 1
Columbus 1
Criciúma 1
Curitiba 1
Da Nang 1
Erbil 1
Exu 1
Fremont 1
Grand Rapids 1
Greensboro 1
Ha Long 1
Hanoi 1
Hanover 1
Itapemirim 1
Jaboatão dos Guararapes 1
Jeddah 1
Johannesburg 1
Juiz de Fora 1
Juneau 1
Leawood 1
Long An 1
Luque 1
Maceió 1
Medellín 1
Mississauga 1
New York 1
Nova Friburgo 1
Pamplona 1
Parobé 1
Phú Thọ 1
Posadas 1
Redwood City 1
Rio de Janeiro 1
Salto 1
Salvador 1
San Francisco 1
Secaucus 1
Seoul 1
Shanghai 1
Sigsig 1
Sorriso 1
São José da Bela Vista 1
São João de Meriti 1
São Paulo 1
São Sebastião 1
Taboão da Serra 1
The Dalles 1
Thái Nguyên 1
Tây Ninh 1
Uberlândia 1
Yên Bái 1
Totale 176
Nome #
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 68
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: A 18-month multicentre study 59
Genetic association of α2-macroglobulin polymorphisms with AD in southern Italy 44
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 44
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 32
Totale 247
Categoria #
all - tutte 2.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 14 2 0 0 1 4 0 0
2021/202217 0 0 0 5 2 0 1 4 0 3 2 0
2022/202322 10 0 3 1 2 1 0 1 1 1 2 0
2023/202420 4 4 4 1 1 4 0 0 0 0 1 1
2024/202559 9 1 1 0 5 7 1 0 6 2 12 15
2025/2026107 13 17 26 33 18 0 0 0 0 0 0 0
Totale 247